Pfizer (PFE) reported Q3 FY 2021 earnings of $1.34 per share (versus $0.59 per share in Q3 FY 2020), beating analysts’ consensus estimate of $1.09 per share.
The company’s quarterly revenues amounted to $24.094 bln (+134.4% y/y), beating analysts’ consensus estimate of $22.820 bln.
PFE rose to $44.95 (+3.00%) in pre-market trading.
